Table 3.
Item | Cancer type, no. (%)*
|
p | |||
---|---|---|---|---|---|
CRC | UGI | EC† | OC† | ||
Believe screening is somewhat or very important | 32/33 (97) | 18/33 (55) | 6/7 (86) | 6/7 (86) | 0.001 |
Told by someone to be screened | NA | 7/34 (21) | 7/7 (100) | 4/7 (57) | <0.001 |
Last screening test occurred recently‡ | 31/33 (94) | 19/34 (56) | 6/7 (86) | 5/7 (71) | 0.004 |
Test was specifically for routine screening†† | 28/34 (82) | 10/21 (48) | 6/6 (100) | 4/6 (75) | 0.053 |
CRC, colorectal cancer; UGI, upper gastrointestinal cancer; EC, endometrial cancer; OC, ovarian cancer.
n = 7 (responses analyzed only from patients eligible for the screening).
For colonoscopy, within the 2 years prior to taking the survey; for UGI endoscopy, within the last 3 years; for endometrial biopsy, within the last year; for transvaginal ultrasound, within the last year.
Denominator is the number of participants who underwent the test This group also included participants who underwent testing owing to “increased risk of cancer in my family”.